155 related articles for article (PubMed ID: 34794221)
1. [The expression of GGCT in the bladder urothelial cell carcinoma and its clinical significance].
Guo YS; Wu YD; Ma H; Qi L; Zhang SD; Zang YJ
Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1183-1187. PubMed ID: 34794221
[No Abstract] [Full Text] [Related]
2. γ-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors.
Takemura K; Kawachi H; Eishi Y; Kitagaki K; Negi M; Kobayashi M; Uchida K; Inoue J; Inazawa J; Kawano T; Board PG
Hum Pathol; 2014 Feb; 45(2):331-41. PubMed ID: 24342434
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of macrophage migration inhibitory factor in bladder urothelial cell carcinoma].
Guo YS; Dai YP; Li W; Liu LD
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):28-31. PubMed ID: 21575460
[TBL] [Abstract][Full Text] [Related]
5. Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
Zhu J; Lu Z; Ke M; Cai X
Int Urol Nephrol; 2022 Jul; 54(7):1505-1512. PubMed ID: 35467245
[TBL] [Abstract][Full Text] [Related]
6. Widespread expression of γ-glutamyl cyclotransferase suggests it is not a general tumor marker.
Amano T; Eishi Y; Yamada T; Uchida K; Minegishi K; Tamura T; Kobayashi D; Hiroshi K; Suzuki T; Board PG
J Histochem Cytochem; 2012 Jan; 60(1):76-86. PubMed ID: 22205682
[TBL] [Abstract][Full Text] [Related]
7. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.
Su JS; Arima K; Hasegawa M; Franco OE; Umeda Y; Yanagawa M; Sugimura Y; Kawamura J
Int J Urol; 2004 Feb; 11(2):74-82. PubMed ID: 14706010
[TBL] [Abstract][Full Text] [Related]
9. Pro-GA, a Novel Inhibitor of γ-Glutamylcyclotransferase, Suppresses Human Bladder Cancer Cell Growth.
Hanada E; Kageyama S; Murai R; Kubota S; Ii H; Nakata S; Kita H; Kawauchi A; Chano T
Anticancer Res; 2019 Apr; 39(4):1893-1898. PubMed ID: 30952730
[TBL] [Abstract][Full Text] [Related]
10. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.
Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J
Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700
[TBL] [Abstract][Full Text] [Related]
11. A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression.
Kawaguchi M; Hara N; Bilim V; Koike H; Suzuki M; Kim TS; Gao N; Dong Y; Zhang S; Fujinawa Y; Yamamoto O; Ito H; Tomita Y; Naruse Y; Sakamaki A; Ishii Y; Tsuneyama K; Inoue M; Itoh J; Yasuda M; Sakata N; Jung CG; Kanazawa S; Akatsu H; Minato H; Nojima T; Asai K; Miura Y
BMC Cancer; 2016 Oct; 16(1):805. PubMed ID: 27756245
[TBL] [Abstract][Full Text] [Related]
12. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic value of carbonic anhydrase IX (CA-IX) in bladder urothelial carcinoma.
Xiang AP; Chen XN; Xu PF; Shao SH; Shen YF
BMC Urol; 2022 Aug; 22(1):120. PubMed ID: 35922856
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
[TBL] [Abstract][Full Text] [Related]
15. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J
J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441
[TBL] [Abstract][Full Text] [Related]
16. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
18. Correlation of REG1A, Claudin 7 and Ki67 expressions with tumor recurrence and prognostic factors in superficial urothelial urinary bladder carcinomas.
Yamuç E; Barışık NÖ; Şensu S; Tarhan F; Barışık CC
Indian J Pathol Microbiol; 2022; 65(2):355-361. PubMed ID: 35435371
[TBL] [Abstract][Full Text] [Related]
19. The relationship between the expression of E-cadherin and tumor recurrence and progression in high-grade stage T1 bladder urothelial carcinoma.
Erdemir F; Ozcan F; Kilicaslan I; Parlaktas BS; Uluocak N; Gokce O
Int Urol Nephrol; 2007; 39(4):1031-7. PubMed ID: 17340210
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of replication protein A3 is associated with unfavorable outcome in bladder urothelial carcinoma.
Sun D; Zhang K; Fu Q; Zhang H; Liu S; Wang H; Xu Z; Wang J
J Cancer Res Ther; 2021 Jul; 17(3):771-776. PubMed ID: 34269312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]